Elderly patients are often not eligible for oral anticoagulant therapy due to the risk of bleeding events or other adverse outcomes. A very low dose of edoxaban, however, appears to be a safe treatment option, even for especially frail patients.

Julius Bogdan, vice president and general manager of the HIMSS Digital Health Advisory Team for North America, explains considerations for healthcare IT teams on the implementation of artificial intelligence (AI).

While MGMA recognized that the No Surprises Act “established critical patient protections against balance billing and created new cost transparency tools to help patients,” the association argued the new requirements for 2022 also carried “ significant additional administrative burdens for group practices.”

The trial to decide if UnitedHealth Group will be allowed to pursue its $13 billion acquisition with Change Healthcare is underway.

Yet another lawsuit is taking aim at the Affordable Care Act, and 61 U.S. medical organizations have joined forces to speak out.

The bill, Advancing Telehealth Beyond COVID–19 Act of 2022, extends telehealth flexibilities under Medicare that were initially authorized during the public health emergency relating to COVID-19.

92% of patients believe privacy is a right and their health data should not be available for purchase by corporations or other individuals.

Treating subclinical leaflet thrombosis after TAVR has been an ongoing challenge for structural heart clinicians, but recent research has gone a long way toward improving our understanding of this important topic.